文献速递分子诊断临床微生物临床免疫

多重PCR即时检测平台在急诊科呼吸道病原体检测中的应用影响

Impact of multiplex PCR point-of-care platform implementation for respiratory pathogen detection in an emergency department with high daily patient volume.
PubMed 文献 · J Clin Microbiol · 2025-12-01

该研究在2023年冬季于Poitiers大学医院急诊科,由受训护士对LRTI症状成人患者采集鼻咽拭子并用Spotfire检测,评估该快速广谱诊断对患者管理的影响。共分析1320份样本,中位周转时间37分钟,540份(41%)阳性;阳性结果与更快的医疗决策、更少的住院和更短的住院时间相关。研究验证了该工具在高流量急诊科的可行性,并改善患者流转、抗菌药物决策和隔离策略。

要点

  • Spotfire中位周转时间37分钟,1320份样本中540份(41%)阳性。
  • 阳性结果与更快医疗决策、更少住院和更短住院时间相关。
  • 43%样本检出四联panel未覆盖的病原体,提示广谱覆盖的附加诊断价值。

核心结论

  • 该研究验证了Spotfire在髙流量急诊科的可行性,并改善患者流转、抗菌药物决策和隔离策略。
  • 近半数病原体可被常规四联检测漏检,支持更广谱综合征覆盖的附加诊断价值。

研究设计与样本

  • 2023年冬季在Poitiers大学医院急诊科开展,受训护士对LRTI症状成人患者采集鼻咽拭子并操作Spotfire。
  • 研究描述病毒流行病学,并通过比较检出与未检出呼吸道病原体患者的管理评估影响与效能。
  • 2023年12月15日至2024年3月15日共分析1320份样本。

主要发现

  • 1320份样本中540份(41%)阳性,中位周转时间37分钟,10份结果不可判读。
  • 主要病毒为甲型流感(30.9%)、鼻病毒/肠病毒(21.1%)和SARS-CoV-2(18.7%),非典型细菌占所有病原体的8%。
  • 43%样本检出四联panel未覆盖的病原体。
  • 阳性结果较阴性结果与更快医疗决策相关(380±234 vs 431±238分钟;P<0.001)。
  • 阳性结果较阴性结果与更少住院(65% vs 78%;P<0.001)和更短住院时间(10±9 vs 12±14天;P=0.006)相关。

临床怎么用

  • 可在高流量急诊科由受训护士操作Spotfire进行呼吸道病原体快速广谱检测以辅助分诊与决策。
  • 检测结果可支持抗菌药物管理,尤其针对肺炎支原体等非典型细菌的 targeted 治疗决策。
  • 广谱覆盖有助于发现四联panel漏检的病原体,优化隔离策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Lower respiratory tract infections (LRTIs) place a substantial burden on emergency departments (EDs) during winter outbreaks. Their microbiological diagnosis is currently based on either broad-spectrum molecular techniques performed in laboratory, with turnaround times incompatible with ED workflows, or point-of-care systems, restricted to SARS-CoV-2, influenza A/B, and RSV (quadriplex panel). The Spotfire combines rapid result and syndromic approach (10 respiratory viruses and 4 atypical bacteria), but its added value in EDs remains unassessed. During the 2023 winter, trained nurses collected nasopharyngeal swabs from adult patients with LRTI symptoms and operated the Spotfire in the ED of the Poitiers University Hospital. We described the viral epidemiology and evaluated the impact and efficacy of this rapid broad-spectrum diagnosis by comparing the management of patients with or without respiratory pathogen detected. From 15 December 2023 to 15 March 2024, 1,320 samples were analyzed with Spotfire, with a median turnaround time of 37 min and 10 uninterpretable results. A total of 540 (41%) were positive. Influenza A (30.9%), rhinovirus/enterovirus (21.1%), and SARS-CoV-2 (18.7%) were the main viruses detected, while atypical bacteria represented 8% of all pathogens. Overall, a pathogen not represented on the quadriplex panel was detected in 43% samples. Positive test results were associated with faster medical decision (380 ± 234 vs 431 ± 238 min; P < 0.001), fewer hospital admissions (65% vs 78%; P < 0.001), and shorter hospital stay (10 ± 9 vs 12 ± 14 days; P = 0.006) than negative test results. Antibiotic therapy was administered to 42 of 43 of Mycoplasma pneumoniae-positive patients (98%) compared with 110 of 1,265 (9%) negative patients. This study validated the feasibility of this new diagnostic tool in high-volume EDs improving patient flow, antimicrobial decisions, and isolation strategies.IMPORTANCEThis study provides the first real-world evidence supporting the use of a broad multiplex PCR platform for respiratory pathogens directly at the point of care in a high-volume emergency department. By enabling the simultaneous detection of 14 viruses and atypical bacteria within 20 min, this system bridges a critical gap between laboratory diagnostics and bedside clinical decision-making. Its implementation proved feasible and reliable, improving patient flow, antimicrobial stewardship, and infection control measures. Nearly half of the pathogens identified would have been missed by conventional quadriplex assays, highlighting the added diagnostic value of broader syndromic coverage. These findings are of interest to both clinicians and microbiologists, as they provide pragmatic evidence to guide the integration of advanced molecular diagnostics into acute-care workflows and to optimize patient management during respiratory infection surges.

来源:J Clin Microbiol,查看原文。版权归原作者所有。

引用

  1. Bigaud B, Marjanovic N, Deroche L, et al. Impact of multiplex PCR point-of-care platform implementation for respiratory pathogen detection in an emergency department with high daily patient volume. J Clin Microbiol. 2025. PMID: 41324513. doi:10.1128/jcm.01313-25

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。